ALVAC(2) melanoma multi-antigen vaccine
Term · Oncology and biomedicine · MLC-T-ONC-010003
A therapeutic cancer vaccine, based on a replication-defective recombinant canarypox virus (ALVAC) encoding multiple melanoma antigens, with potential immunostimulatory and antineoplastic activities. Vaccination with ALVAC(2) melanoma multi-antigen therapeutic vaccine may stimulate the host immune system to mount an immune response against antigen-expressing melanoma cells, resulting in inhibition of tumor growth and/or metastasis.
| Identifier | MLC-T-ONC-010003 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ALVAC(2) melanoma multi-antigen therapeutic vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010003",
"term": "ALVAC(2) melanoma multi-antigen vaccine",
"field": "Oncology and biomedicine",
"definition": "A therapeutic cancer vaccine, based on a replication-defective recombinant canarypox virus (ALVAC) encoding multiple melanoma antigens, with potential immunostimulatory and antineoplastic activities. Vaccination with ALVAC(2) melanoma multi-antigen therapeutic vaccine may stimulate the host immune system to mount an immune response against antigen-expressing melanoma cells, resulting in inhibition of tumor growth and/or metastasis.",
"synonyms": [
"ALVAC(2) melanoma multi-antigen therapeutic vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alvac-2-melanoma-multi-antigen-vaccine/"
}
Record 918 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.